Integrated Advisors Network’s Clearside Biomedical CLSD Stock Holding History

Integrated Advisors Network’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,047	Closed	-$23K	–	649
2022 Q2	$23K	Hold	1,047	–	–	﹤0.01%	653
2022 Q1	$36K	Hold	1,047	–	–	﹤0.01%	651
2021 Q4	$43K	Hold	1,047	–	–	﹤0.01%	615
2021 Q3	$94K	Hold	1,047	–	–	0.01%	594
2021 Q2	$76K	Hold	1,047	–	–	0.01%	570
2021 Q1	$39K	Hold	1,047	–	–	﹤0.01%	536
2020 Q4	$43K	Hold	1,047	–	–	﹤0.01%	492
2020 Q3	$24K	Hold	1,047	–	–	﹤0.01%	431
2020 Q2	$30K	Hold	1,047	–	–	﹤0.01%	437
2020 Q1	$27K	Hold	1,047	–	–	0.01%	367
2019 Q4	$46K	Buy	+1,047	New	+$22K	0.01%	419

Other funds holding CLSD

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $127M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integrated Advisors Network's CLSD Position: Q3 2022 in Review

Integrated Advisors Network sold out of Clearside Biomedical (CLSD) in Q3 2022, closing a stake of 1,047 shares — an estimated $23K sold.

Integrated Advisors Network first reported a position in CLSD in Q4 2019 and held it in 11 quarters. The position peaked at $94K in Q3 2021. 54 funds tracked by Wall St. Rank hold CLSD as of Q3 2022.

Integrated Advisors Network reported no remaining Clearside Biomedical position as of Q3 2022 after selling out during the quarter.
Integrated Advisors Network sold 1,047 Clearside Biomedical shares in Q3 2022, an estimated $23K.
Integrated Advisors Network first reported a position in Clearside Biomedical in Q4 2019 and held it in 11 quarters.
Integrated Advisors Network's Clearside Biomedical position peaked at $94K in Q3 2021.
54 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2022.

Based on Integrated Advisors Network's 13F filing for Q3 2022, filed 8 Nov 2022.